Urolithiasis in HIV-Positive Patients Treated with Atazanavir
Open Access
- 15 October 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (8) , e105-e108
- https://doi.org/10.1086/521930
Abstract
Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization.Keywords
This publication has 8 references indexed in Scilit:
- Atazanavir UrolithiasisNew England Journal of Medicine, 2006
- Atazanavir urinary stones in an HIV-infected patientAIDS, 2006
- HAART-related nephropathies in HIV-infected patientsKidney International, 2005
- Acute interstitial nephritis associated with atazanavir, a new protease inhibitorAmerican Journal of Kidney Diseases, 2004
- Lopinavir–ritonavir (Kaletra) and lithiasisAIDS, 2004
- NELFINAVIR URINARY STONESJournal of Urology, 2002
- Letters to the EditorInternational Journal of STD & AIDS, 1998
- Urinary stones in HIV-1-positive patients treated with indinavirThe Lancet, 1997